In addition to the papers presented at the workshop, there were also discussion periods following the presentations and concluding the whole workshop. The various parts in the present section represent summaries of the different discussions that took place at the end of the workshop, except for the first part, which reports on drugs currently used in the treatment of schistosomiasis and makes recommendations for developing new and better drugs. The other parts in this section present the discussions and recommendations dealing with these areas: epidemiology, infected animal studies, in vitro and in vivo test correlations, and benefit vs. risk correlation. The author of each paper served as a rapporteur for these discussion sessions.
Summary and perspectives
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.